Acceder

Farmas USA

135K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
5,889 / 16,990
#47105

Re: Farmas USA

Joder con los irlandeses ...

---- DEMANDAS AMARIN EN CURSO ---

Amarin Pharma, Inc. et al. v. Andrx Labs, LLC et al.
3:14-cv-03924; filed June 18, 2014 in the District Court of New Jersey

Amarin Pharma, Inc. et al. v. Teva Pharmaceuticals USA, Inc.
2:14-cv-03251; filed June 6, 2014 in the Eastern District of Pennsylvania

Amarin Pharma, Inc. et al v. Teva Pharmaceuticals USA, Inc.
3:14-cv-03558; filed June 4, 2014 in the District Court of New Jersey

Amarin Pharma, Inc. et al. v. Watson Laboratories, Inc. et al.
3:14-cv-03259; filed May 21, 2014 in the District Court of New Jersey

Amarin Pharma, Inc. et al. v. Dr. Reddy's Laboratories, Inc. et al.
3:14-cv-02760; filed April 30, 2014 in the District Court of New Jersey

Amarin Pharma, Inc. et al. v. Roxane Laboratories, Inc.
1:14-cv-00901; filed April 25, 2014 in the Northern District of Ohio

Amarin Pharma, Inc. et al. v. Apotex, Inc. et al.
1:14-cv-02958; filed April 24, 2014 in the Northern District of Illinois

Amarin Pharma, Inc. et al. v. Apotex, Inc. et al.
3:14-cv-02550; filed April 21, 2014 in the District Court of New Jersey

Amarin Pharma, Inc. et al. v. Roxane Laboratories, Inc.
3:14-cv-02551; filed April 21, 2014 in the District Court of New Jersey

Amarin Pharmaceuticals Ireland Ltd. v. Omthera Pharmaceuticals Inc. et al.
1:14-cv-00279; filed March 4, 2014 in the District Court of Delaware

fuente: http://www.patentdocs.org/new_biotech_cases/

AMRN

#47106

Re: Farmas USA

jooo pero si no vimos la correccion reciente de hasta un 25% del IIB es porque andamos como los caballos con orejeras solo mirando pal frente, vigilando el minuto a minuto atentos a los rumores manipuladores de los tweets,y a los precios de cierre intradia como si trader profesionales de corto plazo pero final invertimos a largo plazo, pero como es que nadie avisó que tocaba correcion despues de un semanal como este y un mensual con un RSI de escandalo,claro despues culpamos a los CEO al smart money bla,bla bla y a los dioses y a la mala suerte, al destino a la fecha que nacistes,y humm y en algunos casitos a mi parejita que me estaBa molestando en ese momento y no me dejaba concentrarme, je,je,je y nos ponemos hasta esoteriCos y vamos a un brujo para que nos diga porque no acertamos en bolsa, pero es QUE NOOO MIRAAAMOS LOS GRAFICOOOOS

#47112

Re: Farmas USA

Eddys probablemente sea cierto lo que decía el Dr Kimm CEO de INO que el RS buscaba eso entrar en Rusell entre otras cosas veamos que nos dicen de la F-II del Cancer C.Uterino en Julio y en igual sentido se proyecta DVAX con la solicitud de autorizacion para un RS que supongo sea este verano.
--------
NVAX

Wooow ,.Flu vaccine fierce market, wooow

The MedImmune Specialty Care division of AstraZeneca announced that the U.S. Centers for Disease Control & Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommended that when available, Live Attenuated Influenza Vaccine (LAIV) should be used for healthy children 2 to 8 years of age, who have no contraindications or precautions. The ACIP’s unanimous vote was based on a systematic evidence-based assessment methodology called the Grading of Recommendations Assessment, Development and Evaluation (also known as GRADE).

The decision by the ACIP is an important step toward guiding healthcare professionals in the protection of children, who have a high burden of influenza disease

- See more at: http://www.vaccinenation.org/2014/06/27/cdc-advisory-committee-recommends-preferential-use-live-attenuated-influenza-vaccine-laiv-eligible-children-2-8-years-age/?utm_campaign=Vaccine%20Nation%20PR%2030062014.html&utm_medium=email&utm_source=Eloqua#sthash.eeAIwQzF.dpuf
http://www.vac

Te puede interesar...

- No hay entradas a destacar -

- No hay entradas a destacar -

Brokers destacados